Nothing Special   »   [go: up one dir, main page]

Boros et al., 2012 - Google Patents

Evaluation of the H2 dedpa scaffold and its cRGDyK conjugates for labeling with 64Cu

Boros et al., 2012

Document ID
6874319375209819302
Author
Boros E
Cawthray J
Ferreira C
Patrick B
Adam M
Orvig C
Publication year
Publication venue
Inorganic Chemistry

External Links

Snippet

Studies of the acyclic ligand scaffold H2 dedpa and its derivatives with the peptide cRGDyK for application in copper radiopharmaceuticals are described. Previously shown to be a superb ligand for 67/68Ga, the chelate is now shown to coordinate 64Cu in its derivatized …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules

Similar Documents

Publication Publication Date Title
Boros et al. Evaluation of the H2 dedpa scaffold and its cRGDyK conjugates for labeling with 64Cu
Boros et al. Acyclic chelate with ideal properties for 68Ga PET imaging agent elaboration
Denk et al. Design, synthesis, and evaluation of a low-molecular-weight 11C-labeled tetrazine for pretargeted PET imaging applying bioorthogonal in vivo click chemistry
Stephenson et al. A New Strategy for the Preparation of Peptide-Targeted Radiopharmaceuticals Based on an Fmoc-Lysine-Derived Single Amino Acid Chelate (SAAC). Automated Solid-Phase Synthesis, NMR Characterization, and in Vitro Screening of fMLF (SAAC) G and fMLF [(SAAC− Re (CO) 3)+] G
Lau et al. PET imaging of carbonic anhydrase IX expression of HT-29 tumor xenograft mice with 68Ga-labeled benzenesulfonamides
Meimetis et al. Bioorthogonal Fluorophore Linked DFO Technology Enabling Facile Chelator Quantification and Multimodal Imaging of Antibodies
Ranyuk et al. 68Ga/DOTA-and 64Cu/NOTA-phthalocyanine conjugates as fluorescent/PET bimodal imaging probes
Lutje et al. Anti-CEA antibody fragments labeled with [18F] AlF for PET imaging of CEA-expressing tumors
Adams et al. Multifunctional desferrichrome analogues as versatile 89Zr (IV) chelators for immunoPET probe development
Tosato et al. Copper coordination chemistry of sulfur pendant cyclen derivatives: an attempt to hinder the reductive-induced demetalation in 64/67Cu radiopharmaceuticals
Yazdani et al. Imidazole-based [2+ 1] Re (I)/99mTc (I) complexes as isostructural nuclear and optical probes
Liu et al. Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma
Comba et al. Bispidine dioxotetraaza macrocycles: a new class of bispidines for 64Cu PET imaging
Spreckelmeyer et al. p-NO2–Bn–H4neunpa and H4neunpa–Trastuzumab: Bifunctional Chelator for Radiometalpharmaceuticals and 111In Immuno-Single Photon Emission Computed Tomography Imaging
Hoigebazar et al. Synthesis and characterization of nitroimidazole derivatives for 68Ga-labeling and testing in tumor xenografted mice
Pandya et al. New macrobicyclic chelator for the development of ultrastable 64Cu-radiolabeled bioconjugate
Chan et al. Rhenium and technetium tricarbonyl complexes of N-heterocyclic carbene ligands
Wang et al. H4octox: versatile bimodal octadentate acyclic chelating ligand for medicinal inorganic chemistry
Guillou et al. Methylthiazolyl tacn ligands for copper complexation and their bifunctional chelating agent derivatives for bioconjugation and copper-64 radiolabeling: An example with bombesin
Le Fur et al. Pyclen tri-n-butylphosphonate ester as potential chelator for targeted radiotherapy: from yttrium (III) complexation to 90Y radiolabeling
Leier et al. Radiometal-containing aryl diazonium salts for chemoselective bioconjugation of tyrosine residues
North et al. Toward hypoxia-selective rhenium and technetium tricarbonyl complexes
Schibli et al. Syntheses and Characterization of Dicarbonyl− Nitrosyl Complexes of Technetium (I) and Rhenium (I) in Aqueous Media: Spectroscopic, Structural, and DFT Analyses
Dale et al. Non-cross-bridged tetraazamacrocyclic chelator for stable 64Cu-based radiopharmaceuticals
Damerow et al. Side-by-Side Comparison of Five Chelators for 89Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability